Skip to content

The effect of of photodynamic therapy with methylene blue on the treatment of cutaneous leishmaniosis

Investigation of the effect of of photodynamic therapy with methylene blue on the treatment of cutaneous leishmaniosis

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200803048289N1
Enrollment
8
Registered
2020-08-31
Start date
2020-05-04
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous leishmaniasis. Cutaneous leishmaniasis

Interventions

Intervention group: In this group, methylene blue solution (50µL of 0.5% MB in water) is applied topically on the lesion (before prescribing methylene blue, if there is a crust in ulcerative lesions,

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 65 Years

Inclusion criteria

Inclusion criteria: Newly diagnosed localized cutaneous leishmaniasis confirmed by smear Giemsa sample Less than 12 weeks has elapsed since the onset of the lesion No lesion on face Number of lesions is less than four No sporotricoid form Size of lesion is less than 5 centimeters The lesion is not on joints. Urban leishmaniasis (based on patient's clinical observations and regional epidemiology)

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding Existence of serious or severe underlying diseases (such as heart disease, kidney disease, liver disease, immunodeficiency)

Design outcomes

Primary

MeasureTime frame
UIlcer development and complete lesion epithelialization in ulcerative lesions. Timepoint: Before, during and 12 weeks after the end of treatment. Method of measurement: Clinical observations.;Becoming flat and change in induration diameter in non-ulcerative lesions. Timepoint: Before, during and 12 weeks after the end of treatment. Method of measurement: Clinical observations.;Diameter of induration and erythema and ulcer size. Timepoint: Before, during and 12 weeks after the end of treatment. Method of measurement: Ruler and caliper.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactForough Rakhshanizadeh

Mashhad University of Medical Sciences

rakhshanizadehf@mums.ac.ir+98 51 3802 2406

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026